PubMed Health⌕ Search

Biomedical subjects

A Witkowski

Publications and source records attributed to A Witkowski.

59 records · Page 4Linked to original sources

Inhibition of the functional interaction between fatty acid synthetase and thioesterase II by modification of a single cysteine thiol on the thioesterase.

Medium-chain S-acyl fatty acid synthetase thioester hydrolase (thioesterase II), a discrete, monomeric, serine active-site enzyme, modifies the product specificity of the de novo lipogenic pathway by hydrolyzing the thioester bond linking the growing acyl chain to the 4'-phosphopantetheine of the fatty acid synthetase. The mechanism of interaction of thioesterase II and fatty acid synthetase has been studied by probing the thioesterase with sulfhydryl-modifying reagents. Modification of a single cysteine thiol with 5,5'-dithiobisnitrobenzoate destroyed the ability of thioesterase II to catalyze hydrolysis of S-acyl fatty acid synthetase thioesters but had no effect on the ability of the enzyme to hydrolyze the model substrate, decanoyl-S-pantetheine. The inhibition was readily reversed on removal of the thionitrobenzoate moiety from the thioesterase with dithiothreitol. The results of kinetic experiments indicated that loss of the capacity of the thioesterase to hydrolyze the natural substrate could be attributed to an inability of the 5,5'-dithiobisnitrobenzoate-modified enzyme to bind to the fatty acid synthetase. Modification of the same cysteine thiol with methyl methanethiolsulfonate did not affect the ability of thioesterase II to hydrolyze either the natural or model substrates. The results are interpreted to indicate that cysteine thiol, remote from the catalytic active-site serine residue, is present on a binding domain of the thioesterase which interfaces with the fatty acid synthetase. Modification of this thiol with the large thionitrobenzoate moiety, but not with the small CH3S- moiety, inhibits the functional interaction either by steric hindrance or by perturbation of the polypeptide configuration at the binding domain.

Animals↗

Inhibition of the biosynthesis of deoxyribonucleic acid, ribonucleic acid and protein in HeLa S3 cells by cucurbitacins, glucocorticoid-like cytotoxic triterpenes.

Cucurbitacins were found to inhibit the incorporation of radioactive precursors into DNA, RNA and protein in intact and permeabilized HeLa S3 cells. The observed inhibition was rapid and irreversible although the maximal effect (almost complete inhibition) required several hours of cell exposition to the agent. The magnitude of the inhibition was, with some exceptions, nearly the same for all three precursors within the entire range of cucurbitacin concentrations examined. The ID50 values (concentrations required to produce half-maximal inhibition of the macromolecule biosynthesis) determined for several cucurbitacins were very close to their respective ED50 values (those for half-maximal inhibition of cell proliferation). Parallel with the inhibition of [3H]-labelled precursor incorporations into nucleic acids, cucurbitacin diminished the [3H]thymidine and [3H]uridine nucleotides' pool sizes of HeLa S3 cells. No effect of cucurbitacin on the [3H]leucine pool was observed. The studies presented prove that cucurbitacins inhibit the biosynthesis of DNA, RNA and protein in HeLa S3 cells, and that these inhibitory effects are closely related to the inhibition of HeLa S3 cell proliferation by cucurbitacins. The mechanism of the inhibition is unknown but the obtained results suggest that cucurbitacins act upon an unidentified target, which results in the inhibition of macromolecule biosynthesis. It was also found that these inhibitory effects of cucurbitacins are neither mediated by glucocorticoid receptors nor require replication, transcription or translation.

Antineoplastic Agents↗

Binding of the cytotoxic and antitumor triterpenes, cucurbitacins, to glucocorticoid receptors of HeLa cells.

1. The binding of cucurbitacins to glucocorticoid receptors in HeLa cell-free systems and in intact cells was studied by competition with [3H]cortisol. Cucurbitacins were found to diminish the [3H]cortisol binding. 2. The difference in binding affinity at two temperatures suggest that cucurbitacins are metabolized under physiological conditions. 3. A linear correlation was observed between logarithms of relative binding affinities and of cytotoxic activities of cucurbitacins. Hence, the cucurbitacin binding to glucocorticoid receptors seems to be a necessary step for cytotoxic action of these compounds. 4. Cucurbitacin I was found to form cytoplasmic and nuclear salt-extractable complexes with glucocorticoid receptors of intact HeLa cells at 37 degrees C. Unlike cortisol, cucurbitacin I did not produce salt-resistant nuclear complexes.

Antineoplastic Agents↗